M. K. Proteins Limited (MKPL) Fair Value & Analysis
Consumer Defensive · IN · Market cap ₹1.8B
Fair value as of: Jul 3, 2026
From 23 valuation models · updated today
Share price −2.4% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹3.85 – ₹7.56 · fair‑value band ₹2.00 – ₹3.96 · the ₹4.79 price screens above the ₹3.09 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
M. K. Proteins Limited (MKPL) currently trades at ₹4.79, while our model-based Fair Value estimate is ₹3.09 — implying the stock looks roughly 35.5% overvalued today. We read business quality at 49/100 (below-average quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, M. K. Proteins Limited generated revenue of ₹3.8B at a net margin of 1.8%. Revenue grew 6.4% year over year. It earns a return on equity of 9.4%. Net debt stands at ₹367M. Fundamentals as of Jul 3, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
About the company
M. K. Proteins Limited engages in the manufactures and trades in vegetable refined oil and by-products in India. It offers rice bran, sunflower, cotton seed, soya bean, palm, canola, and rice bran bleached oils. The company also provides by-products, including rice bran fatty acid oils, rice bran waxes, gums, and spent earth; imports, processes, and sells crude oils; and trades in edible and non-edible oils. M. K. Proteins Limited was incorporated in 2012 and is based in Ambala, India.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
M. K. Proteins Limited reported revenue of ₹3.8B in FY2026 versus ₹2.6B in FY2022, a compound +10.6%/yr. Reported net income was ₹68.3M in FY2026, compounding −9.5%/yr from FY2022.
Is MKPL fairly valued? → Check now
Similar stocks
6 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Nestlé S.A NESN | CHF 79.44 | CHF 50.99 | -36% |
| Foshan Haitian Flavouring and Food Company 603288 | ¥33.04 | ¥25.65 | -22% |
| Nestlé India Limited NESTLEIND | ₹1,402 | ₹362.37 | -74% |
| Grupo Bimbo, S.A. BIMBOA | 57.10 MXN | 83.34 MXN | +46% |
| Uni-President Enterprises Corp 1216 | 75.10 TWD | 72.54 TWD | -3% |
| Britannia Industries Limited BRITANNIA | ₹5,121 | ₹1,374 | -73% |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is M. K. Proteins Limited (MKPL) undervalued?
What is the fair value of MKPL?
What is the quality score of MKPL?
What is the revenue of M. K. Proteins Limited (MKPL)?
What is the net profit margin of MKPL?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.